Long-Term Effectiveness of Adalimumab Reported in Patients with Noninfectious Uveitis
Biologic Agents May Reduce Risk of Mental Health Disorders in Some Patients with Psoriasis
Phase 2 Data Support Continued Evaluation of Mitapivat for Alpha, Beta Thalassemia